article thumbnail

Will Facebook's IPO Unbottle Southern California's Pipeline?

socalTECH

Facebook filed for its IPO Wednesday afternoon, saying that it is looking to raise up to $5 billion, in what is expected to be the biggest IPO since Google. Will the filing of an IPO by Menlo Park-based Facebook unclock the pipeline of would-be Southern Calfornia IPOs? The firm reported net income of $1 billion on revenues of $3.7

article thumbnail

Amgen Backs Alector For Alzheimer's Treatment

socalTECH

Thousand Oaks-based biotech giant Amgen is the a new investor in a round for Alector , a developer of immuno-modulatory therapies for Alzheimer's disease and other neurogenerative disorders, which announced a $29.5M funding today. READ MORE>>.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Interview with Brett Crosby and Brew Johnson, PeerStreet

socalTECH

We sat down with Brett Crosby (who founded Urchin Software, the company which became Google Analytics) and Brew Johnson , the co-founders of the company, to learn more about the company and what it's working on. I grew up in Thousand Oaks, went to USC, and we met each other way back in the 90's. in a funding round.

article thumbnail

Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More

Xconomy

Verily is the biotech group at Google’s parent company Alphabet (NASDAQ: [[ticker:GOOG:]]). Adicet raised $51 million earlier this year… Amgen (NASDAQ: AMGN ) of Thousand Oaks, CA, is paying $40 million immediately for rights to ADXS-NEO , a preclinical cancer treatment from Princeton, NJ-based Advaxis (NASDAQ: ADXS ).

article thumbnail

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

Xconomy

—On the positive side, Thousand Oaks, CA-based Amgen (NASDAQ: AMGN ) released an overview of Phase 2 data that showed its migraine prevention drug, erenumab, is keeping pace with rival drugs in a heated race to market.